glp 1 neurotransmitter The function of glucagon-like peptide (GLP-1) in humans. GLP-1, GLP-1 Agonists: Increasing Effective Insulin
Description
Tirzepatide dose-dependently leads to clinically significant reductions in glycemic parameters and body weight and has been shown to have stronger effects in reducing these parameters than standard antidiabetic therapy
If you have type 2 diabetes and use a sulfonylurea (e.g., glipizide, glimepiride, glyburide) or insulin, then consult your primary healthcare provider and/or endocrinologist to ensure the treatment is safe for you with careful monitoring
With tirzepatide, there is now one GIP/GLP-1 receptor dual agonist with a promising development that may find a prominent place in the treatment algorithm for the therapy of T2D and possibly also for obesity
Contact your insurance provider directly
These arise because GLP1 agonists slow stomach emptying and intensify satiety signals, which can leave you feeling uncomfortably full after small meals and trigger food aversions
